ARTEMIS is a multicenter randomized controlled trial. The goal is to understand whether rapid onsite evaluation during robotic assisted bronchoscopy improves the diagnostic performance of the procedure or not.
≥ 18 years of age at time of bronchoscopy
Undergoing robotic assisted bronchoscopy to biopsy a pulmonary lesion
Declines to participate or inability to provide informed consent.
Clinician determination that the use of ROSE is required or contraindicated for the optimal care of an individual patient
Patient enrolled in another trial that requires ROSE for PPL biopsy
Patient previously consented for this trial
Vanderbilt University Medical Center
Lead sponsor
AstraZeneca
Collaborator